Reactive Arthritis (Campylobacter jejuni)
Overview
Plain-Language Overview
Reactive Arthritis (ReA) is a condition that causes inflammation primarily in the joints, often following an infection in the digestive or urinary tract. It mainly affects the musculoskeletal system, leading to symptoms like joint pain, swelling, and stiffness. This condition typically develops a few weeks after an infection with bacteria such as Campylobacter jejuni, which causes intestinal illness. Besides joints, it can also affect the eyes, skin, and urinary tract, causing redness, rashes, or painful urination. The inflammation results from the immune system reacting abnormally to the infection, even though the bacteria are no longer present in the joints. This immune response can cause discomfort and limit movement, impacting daily activities.
Clinical Definition
Reactive Arthritis (ReA) is a sterile inflammatory arthritis triggered by a preceding infection, most commonly involving the gastrointestinal or genitourinary tract. It is characterized by an autoimmune response to bacterial antigens, particularly from Campylobacter jejuni, leading to synovial inflammation without direct joint infection. The pathogenesis involves molecular mimicry and immune complex deposition, often in genetically predisposed individuals carrying the HLA-B27 allele. Clinically, ReA presents with asymmetric oligoarthritis predominantly affecting the lower limbs, enthesitis, and extra-articular manifestations such as conjunctivitis and urethritis. The condition is part of the seronegative spondyloarthropathies group and can cause significant morbidity due to joint pain and systemic symptoms. Diagnosis relies on clinical history, evidence of recent infection, and exclusion of other causes of arthritis.
Inciting Event
Acute gastroenteritis caused by Campylobacter jejuni infection is the typical trigger.
Other enteric infections such as Salmonella and Shigella can also precipitate reactive arthritis.
Genitourinary infections with Chlamydia trachomatis may trigger a similar syndrome.
Latency Period
Symptoms typically develop 1 to 4 weeks after the initial enteric infection.
Latency allows for immune sensitization and development of autoimmune joint inflammation.
Delayed onset can complicate linking arthritis to the preceding infection.
Diagnostic Delay
Lack of awareness of the association between gastroenteritis and arthritis leads to missed diagnosis.
Initial symptoms may be attributed to viral arthritis or septic arthritis, delaying correct diagnosis.
Absence of positive synovial fluid cultures can mislead clinicians away from reactive arthritis.
Clinical Presentation
Signs & Symptoms
Acute asymmetric arthritis developing 1-4 weeks after Campylobacter jejuni enteric infection
Conjunctivitis or painful red eyes often accompanying joint symptoms
Urethritis or dysuria in males as part of the classic triad
Enthesitis causing localized pain at tendon insertions
Low back pain due to sacroiliac joint involvement
Fever and malaise may be present during the acute phase
History of Present Illness
Patients report acute onset of asymmetric oligoarthritis, predominantly affecting lower limb joints.
Preceding diarrheal illness with abdominal cramps and fever is common.
Additional symptoms include enthesitis, conjunctivitis, and urethritis, forming the classic triad.
Arthritis symptoms often wax and wane over weeks to months.
Past Medical History
Recent history of gastrointestinal infection with symptoms of diarrhea and abdominal pain.
Prior episodes of reactive arthritis or other spondyloarthropathies increase recurrence risk.
No history of chronic inflammatory arthritis such as rheumatoid arthritis or lupus.
Family History
Family history of spondyloarthropathies such as ankylosing spondylitis or reactive arthritis is common.
HLA-B27-associated diseases may cluster in families, increasing genetic predisposition.
No direct inheritance pattern but increased risk in first-degree relatives with autoimmune arthritis.
Physical Exam Findings
Asymmetric oligoarthritis predominantly affecting the lower extremities, especially knees and ankles
Enthesitis at tendon insertions such as the Achilles tendon and plantar fascia
Conjunctivitis or anterior uveitis with eye redness and pain
Dactylitis causing sausage-shaped digits
Mucocutaneous lesions including keratoderma blennorrhagicum and circinate balanitis
Diagnostic Workup
Diagnostic Criteria
Diagnosis of reactive arthritis is based on a combination of clinical features including asymmetric oligoarthritis, typically involving the lower extremities, and a history of recent gastrointestinal or genitourinary infection, such as with Campylobacter jejuni. Laboratory tests may show elevated inflammatory markers but negative synovial fluid cultures, confirming sterile joint inflammation. Detection of HLA-B27 supports the diagnosis but is not required. Confirmation involves ruling out other causes of arthritis and identifying evidence of preceding infection through stool cultures or serology. Imaging may reveal characteristic enthesitis or sacroiliitis.
Pathophysiology
Key Mechanisms
Molecular mimicry between Campylobacter jejuni antigens and host joint tissues triggers autoimmune inflammation.
HLA-B27-associated immune dysregulation promotes aberrant T-cell activation and chronic synovitis.
Post-infectious immune complex deposition in synovial membranes contributes to joint inflammation.
Cytokine-mediated inflammation involving TNF-alpha and IL-17 drives enthesitis and arthritis.
| Involvement | Details |
|---|---|
| Organs | Joints are the main organs affected, presenting with asymmetric oligoarthritis. |
Eyes may be involved causing conjunctivitis or anterior uveitis as extra-articular manifestations. | |
| Tissues | Synovial membrane is the primary site of inflammation causing joint swelling and pain. |
Entheses (sites of tendon and ligament insertion) are commonly inflamed leading to enthesitis. | |
| Cells | CD4+ T cells mediate the autoimmune inflammatory response in reactive arthritis. |
Macrophages produce proinflammatory cytokines contributing to joint inflammation. | |
Neutrophils infiltrate synovial fluid causing acute inflammation and tissue damage. | |
| Chemical Mediators | Tumor necrosis factor-alpha (TNF-α) is a key cytokine driving synovial inflammation and joint damage. |
Interleukin-17 (IL-17) promotes neutrophil recruitment and sustains chronic inflammation. | |
Prostaglandins mediate pain and swelling in affected joints. |
Treatments
Pharmacological Treatments
NSAIDs
- Mechanism:
Inhibit cyclooxygenase enzymes to reduce prostaglandin synthesis and decrease inflammation.
- Side effects:
Gastrointestinal bleeding
Renal impairment
Hypertension
- Clinical role:
First-line
Sulfasalazine
- Mechanism:
Modulates immune response by inhibiting inflammatory cytokines and suppressing T-cell proliferation.
- Side effects:
Rash
Leukopenia
Hepatotoxicity
- Clinical role:
Second-line
Corticosteroids
- Mechanism:
Suppress multiple inflammatory pathways by inhibiting cytokine production and immune cell activation.
- Side effects:
Hyperglycemia
Osteoporosis
Immunosuppression
- Clinical role:
Adjunctive
Antibiotics (e.g., macrolides or fluoroquinolones)
- Mechanism:
Target Campylobacter jejuni to eradicate persistent infection triggering reactive arthritis.
- Side effects:
Gastrointestinal upset
Tendonitis
QT prolongation
- Clinical role:
Supportive
Non-pharmacological Treatments
Physical therapy to maintain joint mobility and reduce stiffness.
Rest and joint protection during acute inflammatory episodes.
Patient education on avoiding triggers and managing symptoms.
Prevention
Pharmacological Prevention
No established antibiotic prophylaxis to prevent reactive arthritis after Campylobacter jejuni infection
Early antibiotic treatment of enteric infection may reduce risk but is not definitively preventive
NSAIDs used to control inflammation and may reduce progression if started early
Non-pharmacological Prevention
Proper food handling and cooking to prevent Campylobacter jejuni infection
Hand hygiene after contact with potentially contaminated sources
Avoidance of unpasteurized dairy and contaminated water to reduce exposure risk
Prompt treatment of enteric infections to minimize immune-mediated sequelae
Outcome & Complications
Complications
Chronic arthritis leading to joint damage and deformity in a minority of patients
Recurrent uveitis causing vision impairment if untreated
Enthesopathy resulting in chronic tendon pain and dysfunction
Secondary amyloidosis is a rare complication from prolonged inflammation
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Reactive Arthritis (Campylobacter jejuni) versus Ankylosing Spondylitis
Reactive Arthritis (Campylobacter jejuni) | Ankylosing Spondylitis |
|---|---|
Usually occurs after a gastrointestinal infection, often in young adults | Typically presents in late adolescence to early adulthood (ages 15-30) |
May be associated with HLA-B27, but less consistently | Strong association with HLA-B27 positivity |
Acute or subacute arthritis following infection, often self-limited | Chronic progressive axial skeleton involvement with sacroiliitis |
Reactive Arthritis (Campylobacter jejuni) versus Psoriatic Arthritis
Reactive Arthritis (Campylobacter jejuni) | Psoriatic Arthritis |
|---|---|
Preceding gastrointestinal infection such as Campylobacter jejuni | History of psoriasis or psoriatic skin lesions |
Seronegative arthritis with elevated acute phase reactants post-infection | Usually RF-negative but may have elevated inflammatory markers |
Asymmetric oligoarthritis without erosive changes typical of psoriatic arthritis | Asymmetric oligoarthritis with pencil-in-cup deformities on X-ray |
Reactive Arthritis (Campylobacter jejuni) versus Rheumatoid Arthritis
Reactive Arthritis (Campylobacter jejuni) | Rheumatoid Arthritis |
|---|---|
Seronegative arthritis without RF or anti-CCP antibodies | Positive rheumatoid factor (RF) and anti-CCP antibodies |
Asymmetric oligoarthritis often involving large joints after infection | Chronic symmetric polyarthritis primarily affecting small joints |
No erosive changes early in disease; imaging often normal or shows soft tissue swelling | Joint space narrowing and marginal erosions on X-ray |
Reactive Arthritis (Campylobacter jejuni) versus Post-Streptococcal Reactive Arthritis
Reactive Arthritis (Campylobacter jejuni) | Post-Streptococcal Reactive Arthritis |
|---|---|
Recent gastrointestinal infection with Campylobacter jejuni | Recent streptococcal pharyngitis or skin infection |
Arthritis develops 1-4 weeks after enteric infection | Arthritis develops within 2-3 weeks after streptococcal infection |
Negative ASO titers; diagnosis supported by stool culture or serology for Campylobacter | May have elevated ASO titers indicating recent streptococcal infection |
Reactive Arthritis (Campylobacter jejuni) versus Inflammatory Bowel Disease-associated Arthritis
Reactive Arthritis (Campylobacter jejuni) | Inflammatory Bowel Disease-associated Arthritis |
|---|---|
No underlying chronic inflammatory bowel disease; arthritis follows infection | History of Crohn disease or ulcerative colitis |
Arthritis occurs after enteric infection independent of chronic bowel symptoms | Arthritis often parallels bowel disease activity |
Elevated acute phase reactants but no chronic anemia or bowel inflammation markers | Elevated inflammatory markers with possible anemia of chronic disease |